European Commission logo
English English
CORDIS - EU research results
CORDIS

Unification of treatments and Interventions for Tinnitus patients

Project description

Analysis of treatments for tinnitus patients

Tinnitus is the perception of a phantom sound, and this debilitating condition affects more than 10 % of the general population. Recent studies show that tinnitus prevalence increases over time and with older age, while a variety of patient characteristics such as genotype and aetiology are poorly understood. There is no current consensus on tinnitus treatment. The EU-funded UNITI project aims to develop a predictive computational model based on longitudinal data and to address the question of which treatment approach is optimal for specific patient cases. Clinical, epidemiological, genetic and audiological data will be analysed using existing databases. Predictive factors for different patient groups will be defined, and their prognostic value will be tested in a clinical trial with different groups of patients undergoing different therapies targeting the auditory and central nervous systems.

Objective

Tinnitus is the perception of a phantom sound and the patient’s reaction to it. Tinnitus remains a scientific and clinical enigma of iTinnitus is the perception of a phantom sound and the patient’s reaction to it. Although much progress has been made, tinnitus remains a scientific and clinical enigma of high prevalence and high economic burden. It affects more than 10% of the general population, whereas 1% of the population considers tinnitus their major health issue. Recent cohort studies show that tinnitus prevalence tends to increase over time and with older age. Assuming that there is no cure to be found, the prevalence estimates in Europe would double by 2050. A large variety of patient characteristics - including genotyping, aetiology, and phenotyping - are poorly understood, because integrated systems approaches are still missing to correlate patient`s characteristics to predict responses to combinatorial therapies. Although genetic causes of tinnitus have been neglected for decades, recent findings of genetic analysis in specific subgroups (gender and phenotype) have highlighted that bilateral tinnitus in men reached a heritability of 0.68. This heritability is close to autism, schizophrenia and Attention Deficit Hyperactive Disorder (ADHD). There is no current consensus on tinnitus treatment. UNITI’s overall aim is to deliver a predictive computational model based on existing and longitudinal data attempting to address the question which treatment approach is optimal for a specific patient based on specific parameters. Clinical, epidemiological, medical, genetic and audiological data, including signals reflecting ear-brain communication, will be analysed from existing databases. Predictive factors for different patient groups will be extracted and their prognostic relevance will be tested in a randomized controlled trial (RCT) in which different groups of patients will undergo a combination of therapies targeting the auditory and central nervous systems.

Call for proposal

H2020-SC1-BHC-2018-2020

See other projects for this call

Sub call

H2020-SC1-2019-Two-Stage-RTD

Coordinator

KLINIKUM DER UNIVERSITAET REGENSBURG
Net EU contribution
€ 884 948,75
Address
FRANS JOSEF STRAUSS ALLEE 11
93053 Regensburg
Germany

See on map

Region
Bayern Oberpfalz Regensburg, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 884 948,75

Participants (13)